𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

✍ Scribed by Hyun Cheol Chung; Sun Young Rha; Joon Oh Park; Nae Choon Yoo; Joo Hang Kim; Jae Kyung Roh; Jin Sik Min; Kyong Sik Lee; Byung Soo Kim; Jin Ju Kim

Book ID
110231146
Publisher
Springer US
Year
1998
Tongue
English
Weight
670 KB
Volume
49
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of urokinase-type plasminogen
Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease
✍ Slobodan Miseljic; Susan Galandiuk; Stephen D. Myers; Dr. James L. Wittliff πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 488 KB πŸ‘ 1 views

Surveillance colonoscopy and biopsy are inaccurate methods of predicting the likelihood of ulcerative colitis patients to develop colon carcinoma. We examined uPA and PAI-1 as potential markers for assessing these patients and those with familial polyposis who are at risk of developing colon cancer.

Clinical significance of urokinase-type
Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer
✍ Charles Edo de Bock; Yao Wang πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 336 KB

## Abstract The involvement of the urokinase‐type plasminogen activator (uPA) system in particular has been extensively studied in the pathogenesis of cancer. The molecular role of the uPA receptor (uPAR) is well characterized with its participation in cell migration and extracellular matrix (ECM)